These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9794499)

  • 1. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD.
    Okimoto K; Miyake M; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K
    Pharm Res; 1998 Oct; 15(10):1562-8. PubMed ID: 9794499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
    Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
    Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent.
    Rao VM; Haslam JL; Stella VJ
    J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
    Okimoto K; Rajewski RA; Stella VJ
    J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs).
    Okimoto K; Tokunaga Y; Ibuki R; Irie T; Uekama K; Rajewski RA; Stella VJ
    Int J Pharm; 2004 Nov; 286(1-2):81-8. PubMed ID: 15501004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled porosity-osmotic pump pellets of a poorly water-soluble drug using sulfobutylether-beta-cyclodextrin, (SBE) 7M-beta-CD, as a solubilizing and osmotic agent.
    Sotthivirat S; Haslam JL; Stella VJ
    J Pharm Sci; 2007 Sep; 96(9):2364-74. PubMed ID: 17497739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent.
    Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K
    J Control Release; 1999 Aug; 60(2-3):311-9. PubMed ID: 10425336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release mechanisms of a sparingly water-soluble drug from controlled porosity-osmotic pump pellets using sulfobutylether-beta-cyclodextrin as both a solubilizing and osmotic agent.
    Sotthivirat S; Haslam JL; Lee PI; Rao VM; Stella VJ
    J Pharm Sci; 2009 Jun; 98(6):1992-2000. PubMed ID: 18823032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.
    Sotthivirat S; Haslam JL; Stella VJ
    Int J Pharm; 2007 Feb; 330(1-2):73-81. PubMed ID: 17045435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
    Zia V; Rajewski RA; Stella VJ
    Pharm Res; 2001 May; 18(5):667-73. PubMed ID: 11465424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms.
    Savolainen J; Järvinen K; Taipale H; Jarho P; Loftsson T; Järvinen T
    Pharm Res; 1998 Nov; 15(11):1696-701. PubMed ID: 9833990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of NSC-281612 (4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde), an experimental antineoplastic agent: effects of pH, solvent composition, (SBE)7m-beta-CD, and HP-beta-CD on stability.
    Jumaa M; Chimilio L; Chinnaswamy S; Silchenko S; Stella VJ
    J Pharm Sci; 2004 Mar; 93(3):532-9. PubMed ID: 14762892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD.
    Ma DQ; Rajewski RA; Stella VJ
    Int J Pharm; 1999 Nov; 189(2):227-34. PubMed ID: 10536251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins.
    Zannou EA; Streng WH; Stella VJ
    Pharm Res; 2001 Aug; 18(8):1226-31. PubMed ID: 11587496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites.
    Anraku M; Hiraga A; Iohara D; Pipkin JD; Uekama K; Hirayama F
    Int J Pharm; 2015 Jun; 487(1-2):142-7. PubMed ID: 25882010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
    Fukuda M; Miller DA; Peppas NA; McGinity JW
    Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
    Jain AC; Aungst BJ; Adeyeye MC
    J Pharm Sci; 2002 Jul; 91(7):1659-68. PubMed ID: 12115827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrins.
    Stella VJ; He Q
    Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
    Narisawa S; Stella VJ
    J Pharm Sci; 1998 Aug; 87(8):926-30. PubMed ID: 9687335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associated-Extraction Efficiency of Six Cyclodextrins on Various Flavonoids in Puerariae Lobatae Radix.
    Feng T; Liu F; Sun L; Huo H; Ren X; Wang M
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30591701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.